. 2014 Apr 23;10(2):108–118. doi: 10.3988/jcn.2014.10.2.108

Table 4.

Exclusion group A. List of diseases identified as the probable etiology by review of referral documents and medical records of 150 patients with SFN

graphic file with name jcn-10-108-i004.jpg

^*The drugs responsible were chemotherapeutic drugs, including bortezomib, cisplatin, and thalidomide in 10 of the 15 patients; metronidazole in two of the 15 patients; and adalimumab, interferon alfa, and phenytoin in individual patients, ^†Systemic lupus erythematosus (n=2), psoriatic arthritis (n=2), rheumathoid arthritis (n=2), Churg-Strauss syndrome (n=1), Sjögren syndrome (n=1), unspecified connective tissue disorder (n=1), and Behçet disease (n=1), ^‡Genetically verified Hereditary Sensory Neuropathy II (n=1), clinically suspected Hereditary Sensory Autonomic Neuropathy (n=1), genetically verified Spinocerebellar Ataxia 3 (n=1), and clinically suspected axonal Charcot-Marie-Tooth variant (n=1), ^§Familial amyloid polyneuropathy, ^∥Rectal cancer, ^¶Suspected based on clinical and electrophysiological data, ^**Suspected based on clinical data, ^††Sixteen of 88 patients had multiple possible disease-associated causes simultaneously.

IGT: impaired glucose tolerance, SFN: small fiber neuropathy.